Clinical Trial Update: Anti-Inflammatory Challenge in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for an anti-inflammatory approach in schizophrenia sponsored by Emory University. The study (NCT05823532) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Emory University | Conditions: Schizophrenia | Phase 4 | Status: RECRUITING